florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
florio HAEMO
2021

Share:

florio HAEMO

Haemophilia app and dashboard

Florio GmbH

Haemophilia is a rare blood disorder. Patients can suffer from bleeding events that can result in serious complications like joint damage and high level of pain, especially when they have no access to treatment. The severe nature of this disease can lead to high levels of distress for patients and their families, with an accompanying high burden of treatment regimen. The digital medical device florio HAEMO is developed to support people with haemophilia and their health care professionals (HCPs) in managing this disease. It provides insights based on real-time data and consists of an app for patients and a dashboard for HCPs.

Date of Launch
2020
Development Time
up to 12 months
Target Regions
Europe
Target Groups
Other target groups: People living with heamophilia and their treating healthcare professional teams (patients & doctors)

RELATED PROJECTS